title: Hot Topics in Primary Care: Diagnosis of Cirrhosis and Evaluation of Hepatic Encephalopathy: Common Errors and Their Significance for the PCP.
abstract: Cirrhosis has become the focus of greater attention in recent years largely because of the increasing prevalence of 2 of its most common causes: chronic viral hepatitis and steatohepatitis (a subset of nonalcoholic fatty liver disease [NAFLD]). Cirrhosis is the result of progressive destruction and regeneration of the liver parenchyma due to chronic liver disease (CLD).
authors.affiliation: Liver Transplantation Program, Professor of Medicine, Northwestern Feinberg School of Medicine, Chicago, IL, USA.
authors.forename: Steven L
authors.initials: SL
authors.lastname: Flamm
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D055088:Early Detection of Cancer / Q000379:methods*; D004502:Education, Medical, Continuing; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D006501:Hepatic Encephalopathy / Q000175:diagnosis* / Q000188:drug therapy*; D006801:Humans; D007792:Lactulose / Q000627:therapeutic use; D008103:Liver Cirrhosis / Q000175:diagnosis* / Q000188:drug therapy*; D008113:Liver Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D065626:Non-alcoholic Fatty Liver Disease / Q000175:diagnosis / Q000628:therapy; D017410:Practice Guidelines as Topic; D015995:Prevalence; D011320:Primary Health Care / Q000592:standards*; D012307:Risk Factors; D014481:United States
chemical_list: D000900:Anti-Bacterial Agents; D005765:Gastrointestinal Agents; D007792:Lactulose